Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.
The addition of 177Lu-PSMA-617 to enzalutamide significantly improved overall survival and QOL in patients with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback